Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096200735> ?p ?o ?g. }
- W3096200735 endingPage "796" @default.
- W3096200735 startingPage "783" @default.
- W3096200735 abstract "Despite the benefits offered by biosimilars in terms of cost savings and improved patient access to biological therapies, and an established regulatory pathway in Europe, biosimilar adoption is challenged by a lack of knowledge and understanding among stakeholders such as healthcare professionals and patients about biosimilars, impacting their trust and willingness to use them. In addition, stakeholders are faced with questions about clinical implementation aspects such as switching. This study aims to provide recommendations on how to improve biosimilar understanding and adoption among stakeholders based on insights of healthcare professionals (physicians, hospital pharmacists, nurses), patient(s) (representatives) and regulators across Europe. The study consists of a structured literature review gathering original research data on stakeholder knowledge about biosimilars, followed by semi-structured interviews across five stakeholder groups including physicians, hospital pharmacists, nurses, patient(s) (representatives) and regulators across Europe. Although improvement in knowledge was observed over time, generally low to moderate levels of awareness, knowledge and trust towards biosimilars among healthcare professionals and patients are identified in literature (N studies = 106). Based on the provided insights from interviews with European experts (N = 44), a number of challenges regarding biosimilar stakeholder understanding are identified, including a lack of practical information about biosimilars and their use, a lack of understanding about biosimilar concepts and a lack of knowledge about biologicals in general. Misinformation by originator industry is also believed to have impacted stakeholder trust. In terms of possible solutions and actions to improve stakeholder understanding, broad support exists to (1) organize initiatives focussed on explaining the rationale behind biosimilar concepts and the approval pathway, (2) invest in education about biologicals in general, (3) develop clear and one-voice regulatory guidance about biosimilar interchangeability and switching across Europe, (4) disseminate real-world clinical biosimilar (switch) data, (5) share biosimilar experiences by key opinion leaders and among peers, (6) provide practical biosimilar product information, (7) provide guidance about biosimilar use, (8) actively counterbalance misinformation and organize information initiatives by neutral entities, (9) organize multi-stakeholder informational and educational efforts, aligning information between involved stakeholder groups and (10) design initiatives in a way that ensures active information uptake. Furthermore, interviewees argue that governments should be proactive in these regards. This study argues in favour of a structural, multi-stakeholder framework at both European and national level to improve stakeholder biosimilar understanding and acceptance. It proposes a number of actionable recommendations that can inform policy making and guide stakeholders, which can contribute to realizing healthcare system benefits offered by biosimilar competition." @default.
- W3096200735 created "2020-11-09" @default.
- W3096200735 creator A5004254550 @default.
- W3096200735 creator A5016982472 @default.
- W3096200735 creator A5047342188 @default.
- W3096200735 creator A5082978640 @default.
- W3096200735 date "2020-11-03" @default.
- W3096200735 modified "2023-10-18" @default.
- W3096200735 title "European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption" @default.
- W3096200735 cites W1971471395 @default.
- W3096200735 cites W2023193839 @default.
- W3096200735 cites W2049274660 @default.
- W3096200735 cites W2052230616 @default.
- W3096200735 cites W2167582510 @default.
- W3096200735 cites W2321204155 @default.
- W3096200735 cites W2340269476 @default.
- W3096200735 cites W2342398417 @default.
- W3096200735 cites W2413214806 @default.
- W3096200735 cites W2462509855 @default.
- W3096200735 cites W2479896075 @default.
- W3096200735 cites W2498475339 @default.
- W3096200735 cites W2527733379 @default.
- W3096200735 cites W2545293585 @default.
- W3096200735 cites W2553537361 @default.
- W3096200735 cites W2560149008 @default.
- W3096200735 cites W2581281042 @default.
- W3096200735 cites W2589872684 @default.
- W3096200735 cites W2613299853 @default.
- W3096200735 cites W2739978627 @default.
- W3096200735 cites W2754502404 @default.
- W3096200735 cites W2793866077 @default.
- W3096200735 cites W2810182033 @default.
- W3096200735 cites W2883934894 @default.
- W3096200735 cites W2889381861 @default.
- W3096200735 cites W2890461594 @default.
- W3096200735 cites W2897025489 @default.
- W3096200735 cites W2901086033 @default.
- W3096200735 cites W2912903554 @default.
- W3096200735 cites W2922098133 @default.
- W3096200735 cites W2980517692 @default.
- W3096200735 cites W2995973342 @default.
- W3096200735 cites W3014370677 @default.
- W3096200735 cites W3015900213 @default.
- W3096200735 cites W3044372145 @default.
- W3096200735 cites W3092981613 @default.
- W3096200735 doi "https://doi.org/10.1007/s40259-020-00452-9" @default.
- W3096200735 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7669769" @default.
- W3096200735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33141421" @default.
- W3096200735 hasPublicationYear "2020" @default.
- W3096200735 type Work @default.
- W3096200735 sameAs 3096200735 @default.
- W3096200735 citedByCount "32" @default.
- W3096200735 countsByYear W30962007352020 @default.
- W3096200735 countsByYear W30962007352021 @default.
- W3096200735 countsByYear W30962007352022 @default.
- W3096200735 countsByYear W30962007352023 @default.
- W3096200735 crossrefType "journal-article" @default.
- W3096200735 hasAuthorship W3096200735A5004254550 @default.
- W3096200735 hasAuthorship W3096200735A5016982472 @default.
- W3096200735 hasAuthorship W3096200735A5047342188 @default.
- W3096200735 hasAuthorship W3096200735A5082978640 @default.
- W3096200735 hasBestOaLocation W30962007351 @default.
- W3096200735 hasConcept C126322002 @default.
- W3096200735 hasConcept C144133560 @default.
- W3096200735 hasConcept C160735492 @default.
- W3096200735 hasConcept C17744445 @default.
- W3096200735 hasConcept C197934379 @default.
- W3096200735 hasConcept C199539241 @default.
- W3096200735 hasConcept C201305675 @default.
- W3096200735 hasConcept C2780984029 @default.
- W3096200735 hasConcept C3019806175 @default.
- W3096200735 hasConcept C39549134 @default.
- W3096200735 hasConcept C41008148 @default.
- W3096200735 hasConcept C56739046 @default.
- W3096200735 hasConcept C57658597 @default.
- W3096200735 hasConcept C59491497 @default.
- W3096200735 hasConcept C71924100 @default.
- W3096200735 hasConcept C98274493 @default.
- W3096200735 hasConceptScore W3096200735C126322002 @default.
- W3096200735 hasConceptScore W3096200735C144133560 @default.
- W3096200735 hasConceptScore W3096200735C160735492 @default.
- W3096200735 hasConceptScore W3096200735C17744445 @default.
- W3096200735 hasConceptScore W3096200735C197934379 @default.
- W3096200735 hasConceptScore W3096200735C199539241 @default.
- W3096200735 hasConceptScore W3096200735C201305675 @default.
- W3096200735 hasConceptScore W3096200735C2780984029 @default.
- W3096200735 hasConceptScore W3096200735C3019806175 @default.
- W3096200735 hasConceptScore W3096200735C39549134 @default.
- W3096200735 hasConceptScore W3096200735C41008148 @default.
- W3096200735 hasConceptScore W3096200735C56739046 @default.
- W3096200735 hasConceptScore W3096200735C57658597 @default.
- W3096200735 hasConceptScore W3096200735C59491497 @default.
- W3096200735 hasConceptScore W3096200735C71924100 @default.
- W3096200735 hasConceptScore W3096200735C98274493 @default.
- W3096200735 hasIssue "6" @default.
- W3096200735 hasLocation W30962007351 @default.
- W3096200735 hasLocation W30962007352 @default.
- W3096200735 hasLocation W30962007353 @default.